These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36208926)

  • 1. Colorectal cancer in patients with diabetes - epidemiology, pathophysiology and applications for clinical practice.
    Romanová A; Malinovská J; Lustigová M; Urbanová J; Brunerová L; Vejtasová V; Verma A; Duong TA; Šťovíček J; Brož J
    Vnitr Lek; 2022; 68(2):116-122. PubMed ID: 36208926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 2 diabetes mellitus as risk factor for colorectal cancer.
    Berster JM; Göke B
    Arch Physiol Biochem; 2008 Feb; 114(1):84-98. PubMed ID: 18465362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 diabetes impacts colorectal adenoma detection in screening colonoscopy.
    Ottaviano LF; Li X; Murray M; Frye JT; Lung BE; Zhang YY; Yang J; Taub EM; Bucobo JC; Buscaglia JM; Li E; Miller JD
    Sci Rep; 2020 May; 10(1):7793. PubMed ID: 32385343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Horizons: Epidemiology of Obesity, Diabetes Mellitus, and Cancer Prognosis.
    Harborg S; Kjærgaard KA; Thomsen RW; Borgquist S; Cronin-Fenton D; Hjorth CF
    J Clin Endocrinol Metab; 2024 Mar; 109(4):924-935. PubMed ID: 37552777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Colorectal carcinoma screening in patients with type 2 diabetes mellitus].
    Nagel JM; Göke B
    Z Gastroenterol; 2006 Nov; 44(11):1153-65. PubMed ID: 17115358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between type-2 diabetes and use of metformin with risk of colorectal adenoma in an American population receiving colonoscopy.
    Kanadiya MK; Gohel TD; Sanaka MR; Thota PN; Shubrook JH
    J Diabetes Complications; 2013; 27(5):463-6. PubMed ID: 23755906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Colorectal carcinoma and diabetes mellitus].
    Procházka V; Chlup R
    Vnitr Lek; 2008 Oct; 54(10):979-84. PubMed ID: 19009765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal cancer outcomes, recurrence, and complications in persons with and without diabetes mellitus: a systematic review and meta-analysis.
    Stein KB; Snyder CF; Barone BB; Yeh HC; Peairs KS; Derr RL; Wolff AC; Brancati FL
    Dig Dis Sci; 2010 Jul; 55(7):1839-51. PubMed ID: 19731028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin therapy and colorectal adenoma risk among patients with Type 2 diabetes mellitus: a case-control study in Korea.
    Chung YW; Han DS; Park KH; Eun CS; Yoo KS; Park CK
    Dis Colon Rectum; 2008 May; 51(5):593-7. PubMed ID: 18219529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 2 diabetes mellitus: the impact on colorectal adenoma risk in women.
    Elwing JE; Gao F; Davidson NO; Early DS
    Am J Gastroenterol; 2006 Aug; 101(8):1866-71. PubMed ID: 16790036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 2 diabetes mellitus and colorectal neoplasia risk in Hispanics: a case-control study.
    Díaz-Algorri Y; Lozada ME; López SM; Bertrán-Rodríguez CE; González-Hernández CM; González D; Pérez-Cardona CM; Hernández J; Pedrosa C; Toro DH; González-Pons M; Cruz-Correa M
    J Diabetes Complications; 2015; 29(4):502-7. PubMed ID: 25784088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of pre-existing type 2 diabetes in colorectal cancer survival among older Americans: a SEER-Medicare population-based study 2002-2011.
    El Brahimi S; Smith ML; Pinheiro PS
    Int J Colorectal Dis; 2019 Aug; 34(8):1467-1475. PubMed ID: 31289849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of colorectal adenoma with components of metabolic syndrome.
    Kim BC; Shin A; Hong CW; Sohn DK; Han KS; Ryu KH; Park BJ; Nam JH; Park JW; Chang HJ; Choi HS; Kim J; Oh JH
    Cancer Causes Control; 2012 May; 23(5):727-35. PubMed ID: 22450737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective investigation of body mass index, colorectal adenoma, and colorectal cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Kitahara CM; Berndt SI; de González AB; Coleman HG; Schoen RE; Hayes RB; Huang WY
    J Clin Oncol; 2013 Jul; 31(19):2450-9. PubMed ID: 23715565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of colorectal cancer in patients with type 2 diabetes: associations with treatment stage and obesity.
    Peeters PJ; Bazelier MT; Leufkens HG; de Vries F; De Bruin ML
    Diabetes Care; 2015 Mar; 38(3):495-502. PubMed ID: 25552419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Colorectal cancer and diabetes].
    Svacina S
    Vnitr Lek; 2011 Apr; 57(4):378-80. PubMed ID: 21612063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and risk factors of metachronous colorectal neoplasm after curative resection of colorectal cancer in Korean patients.
    Lee SY; Kim BC; Han KS; Hong CW; Sohn DK; Park SC; Kim SY; Baek JY; Chang HJ; Kim DY; Oh JH
    J Dig Dis; 2014 Jul; 15(7):367-76. PubMed ID: 24773758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of impaired glucose tolerance and diabetes mellitus to colorectal adenomas in Japan.
    Marugame T; Lee K; Eguchi H; Oda T; Shinchi K; Kono S
    Cancer Causes Control; 2002 Dec; 13(10):917-21. PubMed ID: 12588087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulation in cancer patients; new recommendations based on randomized clinical trials.
    Musil D
    Vnitr Lek; 2022; 68(2):111-115. PubMed ID: 36208925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Distribution characteristics and risk factors of colorectal adenomas].
    Zhou H; Shen Z; Zhao J; Zhou Z; Xu Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jun; 21(6):678-684. PubMed ID: 29968244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.